Clinical Trials

In addition to providing compassionate patient care, our clinicians are committed to advancing the field of gastroenterology through clinical research, including clinical trials.

Clinical trials are research studies that are vital for determining whether discoveries made in basic science research laboratories are effective for improving patient care.

Patients who visit Weill Cornell Medicine, including the DIGEST program, have access to a wide range of clinical trials that are evaluating new diagnostic and therapeutic approaches.

There are several clinical trials related to the DIGEST program that are currently active:

• A Multicenter Randomized Trial of Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients with Barrett’s Esophagus Undergoing Surveillance (The SWAT-BE Study) 23-02025718

• A Phase 3, Double-Blind, Randomized, Two-Phase, Active Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patients With Erosive Esophagitis 22-10025272

• The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma 21-02023380

You can visit the Joint Clinical Trials Office website for a list of clinical trials in open recruitment.